- Home
- GEO vs CNTA Comparison
GEO vs CNTA Comparison
Compare GEO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEO | CNTA |
|---|---|---|
| Founded | 1984 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 3.7B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GEO | CNTA |
|---|---|---|
| Price | $16.04 | $25.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $41.00 | $37.70 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 515.49 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $2,531,574,000.00 | $15,000,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $15.02 | N/A |
| P/E Ratio | $9.51 | ★ N/A |
| Revenue Growth | 4.43 | ★ 118.88 |
| 52 Week Low | $14.27 | $9.60 |
| 52 Week High | $36.46 | $30.58 |
Technical Indicators
Market Signals| Indicator | GEO | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 41.94 |
| Support Level | $16.11 | $24.17 |
| Resistance Level | $16.53 | $26.01 |
| Average True Range (ATR) | 0.53 | 1.14 |
| MACD | -0.06 | -0.26 |
| Stochastic Oscillator | 9.33 | 18.64 |
Price Performance
Historical ComparisonAbout GEO Geo Group Inc (The) REIT
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.